open access

Vol 8, No 2 (2007): Practical Diabetology
Review paper
Published online: 2007-03-02
Get Citation

Pathogenesis, risk factors and clinical impact of post transplant diabetes mellitus after renal transplantation

Barbara Brzezińska, Roman Junik, Zbigniew Włodarczyk, Andrzej Adamowicz
Diabetologia Praktyczna 2007;8(2):64-69.

open access

Vol 8, No 2 (2007): Practical Diabetology
Review articles (submitted)
Published online: 2007-03-02

Abstract

Post transplant diabetes mellitus (PTDM) is one of the most significant a complications after renal transplantation. PTDM is diabetes mellitus which develops de novo after renal transplantation. Pathophysiology has important similarities to type 2 Diabetes Mellitus in that there is coexisting insulin resistance and insulin hyposecretion. Thus, pathogenesis appears to be multifactorial due to the combination of the background of previously existing opposing factors determined by age, ethnicity, genetic and lifestyle compounded by pre existing chronic kidney disease and the use of immunosuppressive drugs such as corticosteroids and calcineurin inhibitors. PTDM is associated with an increased level of mortality and cardiac disease, an increased risk of infection with sepsis being a major cause of death. Furthermore, hyperglycaemia is associated with an increased risk of allograft rejection, and horse graft function. Survival is associated with a reduced quality of life in transplant recipients. The prevention, possible early diagnosis and effective treatment of PTDM are necessary in the prevention of chronic complications caused by diabetes and to improve the prognosis and quality of patient’s life.

Abstract

Post transplant diabetes mellitus (PTDM) is one of the most significant a complications after renal transplantation. PTDM is diabetes mellitus which develops de novo after renal transplantation. Pathophysiology has important similarities to type 2 Diabetes Mellitus in that there is coexisting insulin resistance and insulin hyposecretion. Thus, pathogenesis appears to be multifactorial due to the combination of the background of previously existing opposing factors determined by age, ethnicity, genetic and lifestyle compounded by pre existing chronic kidney disease and the use of immunosuppressive drugs such as corticosteroids and calcineurin inhibitors. PTDM is associated with an increased level of mortality and cardiac disease, an increased risk of infection with sepsis being a major cause of death. Furthermore, hyperglycaemia is associated with an increased risk of allograft rejection, and horse graft function. Survival is associated with a reduced quality of life in transplant recipients. The prevention, possible early diagnosis and effective treatment of PTDM are necessary in the prevention of chronic complications caused by diabetes and to improve the prognosis and quality of patient’s life.
Get Citation

Keywords

post transplant diabetes mellitus; renal transplantation; risk factors of diabetes; immunosuppressive drugs

About this article
Title

Pathogenesis, risk factors and clinical impact of post transplant diabetes mellitus after renal transplantation

Journal

Clinical Diabetology

Issue

Vol 8, No 2 (2007): Practical Diabetology

Article type

Review paper

Pages

64-69

Published online

2007-03-02

Bibliographic record

Diabetologia Praktyczna 2007;8(2):64-69.

Keywords

post transplant diabetes mellitus
renal transplantation
risk factors of diabetes
immunosuppressive drugs

Authors

Barbara Brzezińska
Roman Junik
Zbigniew Włodarczyk
Andrzej Adamowicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl